Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Generated Narrative: ResearchStudy
Resource ResearchStudy "208285" Version "2" Updated "2024-03-19 10:25:13+0000"
url: https://fevir.net/resources/ResearchStudy/208285
identifier: FEvIR Object Identifier/208285, REK project number/2010/2329
name: Year_2018_Norwegian_Cohort_Study
title: Norwegian Cohort Study Comparing Bariatric Surgery vs Medical Obesity Treatment for Long-term Medical Complications and Obesity-Related Comorbidities
label
type: Official title (Title Type#official)
value: The Long-Term Effect of Treatment of Morbid Obesity
label
type: LETMO (Title Type#acronym "Acronym")
label
type: Short title (Title Type#short-title)
value: LETMO - a cohort study
relatedArtifact
type: specification-of
label: Protocol
display: eAppendix 2. Research Protocol
document
relatedArtifact
type: derived-from
resourceReference: Citation/104116: JournalArticleCitation: Association of Bariatric Surgery with Complications and Comorbidities JAMA 2018 Norwegian Cohort
status: active
studyDesign: Observational research (sevco#SEVCO:01002), Parallel cohort design (sevco#SEVCO:01011), Longitudinal data collection (sevco#SEVCO:01028)
condition: morbid obesity ()
region: Norway ()
description: The main purpose of this study is, in combination with data from the Register and Biobank study and follow-up data from the Norwegian Prescription Database, to compare the long-term effects (4-10 years) of surgical and non-surgical treatment of morbid obesity on obesity related comorbidities by studying changes in medicine usage after treatment. Hypotheses 1. Primary hypothesis: As compared to non-surgical treatment, bariatric surgery will be associated with higher rates of remission, and lower rates of new-onset drug treated hypertension during a follow-up period of ≤ 10 years. 2. Secondary hypotheses: Changes in the usage of other drugs, particularly drugs related to obesity related comorbidities, will differ significantly between patients undergoing bariatric surgery or non-surgical treatment during the follow-up period.
period: 2010-07 --> 2015
site: : Vestfold Hospital Trust
associatedParty
name: Jøran Hjelmesæth, Leader of the Morbid Obesity Center, Vestfold Hospital Trust, and Professor at the Department for Endocrinology, Morbid Obesity and Preventitive Medicine, Medical Clinic, the Institute for Clinical Medicine, the University of Oslo.
role: Project Leader and Main Supervisor (Research Study Party Role#primary-investigator "primary-investigator")
associatedParty
name: Gunn Signe Jakobsen, cand. med. at the Morbid Obesity Center, South-Eastern Norway Regional Health Authority. Doctor with a specialisation at the department for Gastroenterological Surgery, Akershus University Hospital. Mobil: 916 25 647, email: gunn.signe.jakobsen@siv.no
role: PhD Candidate (Research Study Party Role#collaborator "collaborator")
associatedParty
name: Jens Kristoffer Hertel, PhD, the Morbid Obesity Center, Vestfold Hospital Trust.
role: Co-supervisor (Research Study Party Role#collaborator "collaborator")
associatedParty
name: Arild Nesbakken, Professor, the Surgical Clinic, Oslo University Hospital
role: Co-supervisor (Research Study Party Role#collaborator "collaborator")
associatedParty
name: Rune Sandbu, dr.med, the Morbid Obesity Center and Department of Surgery, Vestfold Hospital Trust.
role: Co-supervisor (Research Study Party Role#collaborator "collaborator")
associatedParty
name: Milada Cvancarova Småstuen, PhD, the Morbid Obesity Center, South-Eastern Norway Regional Health Authority, Vestfold Hospital Trust
role: Biostatistician (Research Study Party Role#collaborator "collaborator")
State |
Completed (Research Study Status#completed) |
TargetNumber | ActualNumber | ActualGroup |
505 | 1888 | Group/178427: StudyGroup: Severely Obese Adults 2018 Norwegian Cohort "Severely_Obese_Adults_2018_Norwegian_Cohort" |
comparisonGroup
name: Bariatric Surgery
observedGroup: Group/172934: ExposureGroup: JAMA 2018 Norwegian cohort study Surgery cohort "ExposureGroup_JAMA_2018_Norwegian_cohort_study_Surgery_cohort"
comparisonGroup
description: Medical Obesity Treatment
observedGroup: Group/172939: ComparatorGroup: JAMA 2018 Norwegian cohort study Control cohort "ComparatorGroup_JAMA_2018_Norwegian_cohort_study_Control_cohort"
outcomeMeasure
name: Remission of diabetes
reference: EvidenceVariable/104117: OutcomeVariable: Remission of diabetes "OutcomeVariable_Remission_of_diabetes"
outcomeMeasure
name: New onset depression
reference: EvidenceVariable/104118: OutcomeVariable: New onset depression "OutcomeVariable_New_onset_depression"
outcomeMeasure
name: Treatment with opioids
reference: EvidenceVariable/104119: OutcomeVariable: Treatment with opioids "OutcomeVariable_Treatment_with_opioids"
outcomeMeasure
name: Additional GI surgical procedure
reference: EvidenceVariable/104120: OutcomeVariable: Additional GI surgical procedure "OutcomeVariable_Additional_GI_surgical_procedure"
result: